中卵泡期重组黄体生成素与尿源人绒毛膜促性腺激素补充对体外受精中卵巢低反应者的效果:前瞻性双盲随机研究
该前瞻性双盲随机研究纳入49例符合博洛尼亚标准的卵巢低反应(POR)女性,在固定促性腺激素释放激素(GnRH)拮抗剂方案IVF周期中比较中卵泡期重组黄体生成素(rLH)与尿源人绒毛膜促性腺激素(uHCG)补充的效果。结果显示周期取消率、获卵数、受精率、胚胎数、着床率、临床妊娠率和活产率均无统计学显著差异,但uHCG组每启动周期活产率(29.2%)为rLH组(8.0%)的3.6倍;作者指出需进一步研究验证uHCG是否较rLH产生更好的临床结局。
要点
- 在固定GnRH拮抗剂方案IVF周期中,中卵泡期rLH与uHCG补充的周期取消率、获卵数、受精率、胚胎数、着床率、临床妊娠率和活产率均无统计学显著差异。
- uHCG组每启动周期活产率为29.2%,rLH组为8.0%,uHCG组为rLH组的3.6倍。
- 作者指出需进一步研究验证uHCG补充是否较rLH在POR女性中产生更好的临床结局。
核心结论
- 在符合博洛尼亚标准的POR女性中,固定GnRH拮抗剂方案IVF周期中卵泡中期rLH与uHCG补充在周期取消率、获卵数、受精率、胚胎数、着床率、临床妊娠率和活产率上均无统计学显著差异。
- uHCG组每启动周期活产率(29.2%)为rLH组(8.0%)的3.6倍。
- 作者指出需进一步研究验证uHCG补充是否较rLH在POR女性中产生更好的临床结局。
研究设计与样本
- 前瞻性双盲随机研究,共纳入49例符合博洛尼亚标准的卵巢低反应(POR)女性。
- 在固定促性腺激素释放激素(GnRH)拮抗剂方案IVF周期中,于中卵泡期分别补充重组黄体生成素(rLH)或尿源人绒毛膜促性腺激素(uHCG)。
主要发现
- 周期取消率、每启动周期获卵数、受精率、每启动周期获得胚胎数、着床率、临床妊娠率和活产率在rLH组与uHCG组间均无统计学显著差异。
- uHCG组每启动周期活产率为29.2%,rLH组为8.0%,uHCG组为rLH组的3.6倍。
局限性
- 作者指出需进一步研究验证uHCG补充是否较rLH在POR女性中产生更好的临床结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Luteinizing hormone (LH) is crucial for the development of follicular growth and oocyte maturation, especially in the management of poor ovarian responders (PORs). This study presents the results of a prospective double-blinded randomized study to compare the effect of mid-follicular phase recombinant LH (rLH) supplementation with urinary human chorionic gonadotrophin (uHCG) supplementation when using a fixed gonadotrophin-releasing hormone (GnRH) antagonist protocol in IVF cycles. A total of 49 women with poor ovarian response (POR) according to the Bologna criteria were recruited. This study showed no statistically significant difference in cycle cancellation rates, numbers of oocytes retrieved per cycle initiated, fertilization rates, the numbers of embryos obtained per cycle initiated, implantation, clinical pregnancy and live birth rates, although the live birth rate per cycle initiated in the uHCG group (29.2%) was 3.6 times that of the rLH group (8.0%). Further studies are required to verify if uHCG supplementation produces better clinical outcomes compared with rLH in women with POR.
引用
- Mak SM, Wong WY, Chung HS, et al. Effect of mid-follicular phase recombinant LH versus urinary HCG supplementation in poor ovarian responders undergoing IVF - a prospective double-blinded randomized study. Reprod Biomed Online. 2016. PMID: 28063801. doi:10.1016/j.rbmo.2016.11.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。